Sana Biotechnology, Inc. (SANA): Insider Trading, Congress Trades & Research | Tormere
SANA
$2.37+1.28%
Sana Biotechnology, Inc.
Market Cap
$710M
Live price × SEC shares (Oct 29, 2026)
Sector
Health Care
Industry
Biotechnology
Beta (raw)
2.29
60mo monthly vs SPY
P/E (TTM)
N/M
TTM to Sep 2026 · negative earnings
P/S (TTM)
—
Mkt cap / TTM revenue
P/B
3.9
Mkt cap / shareholders' equity
EV/EBITDA (TTM)
—
EV / TTM EBITDA
Loading…
Financial Statements
USD thousands
Q4 FY2025
Dec 31, 2025
Q1 FY2026
Mar 31, 2026
Q2 FY2026
Jun 30, 2026
Q3 FY2026
Sep 30, 2026
TTM
Sep 30, 2026
Research & development
34,924
28,719
30,729
33,930
128,302
Total operating expenses
61,199
48,614
65,420
(18,506)
156,727
Operating income
(61,199)
(48,614)
(65,420)
18,506
(156,727)
Net income
(58,825)
(47,210)
(63,635)
20,401
(149,269)
EPS (basic) ($)
(0.17)
(0.22)
0.07
(0.52)
EPS (diluted) ($)
(0.17)
(0.22)
0.07
(0.52)
Weighted avg. shares (basic)
276,856
295,667
307,002
Weighted avg. shares (diluted)
276,856
295,667
308,790
Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 5, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Showing the last 5 quarters. 23 more quarters, back to Mar 2020, with Tormere Pro.
